Status:
COMPLETED
Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 1
Eligibility:
All Genders
Brief Summary
This trial is conducted in Europe. The aim of this observational study is to evaluate the glycaemic control in patients with type 1 or 2 diabetes using NovoMix® 30 or Levemir® under normal clinical pr...
Eligibility Criteria
Inclusion
- Levemir® above 6 yrs
- NovoMix® 30 above 18 yrs
- Patients with Type 1 or Type 2 diabetes, including newly diagnosed
Exclusion
- Current treatment with NovoMix® 30 or Levemir®
Key Trial Info
Start Date :
May 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
1569 Patients enrolled
Trial Details
Trial ID
NCT00665093
Start Date
May 1 2007
End Date
January 1 2008
Last Update
January 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Skopje, North Macedonia, MK-1000